Carl Zeiss Meditec AG logo

Carl Zeiss Meditec AG

CZMWY | OTC
Chart Builder DCF Calculator
$40.23
+$0.02 (+0.05%)
At close: Nov 5, 2026, 3:25 PM ET
$40.40
+$0.17 (+0.42%)
Pre-market: Nov 5, 2026, 11:29 AM ET
Fiscal Year
Period Ending
FY 2025
Sep 30, 2025
FY 2024
Sep 30, 2024
FY 2023
Sep 30, 2023
FY 2022
Sep 30, 2022
FY 2021
Sep 30, 2021
FY 2020
Sep 30, 2020
Net Income
142.35M 178.73M 292.01M 293.91M 237.52M 123.42M
Depreciation & Amortization
126.38M 132.77M 74.06M 69.77M 61.58M 60.43M
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a
Other Working Capital
27.95M 32.41M 805K 5.76M 61.04M -5.69M
Other Non-Cash Items
-22.2M -79.28M 10.67M -58.64M 11.69M 2.18M
Deferred Income Tax
n/a n/a n/a -7.33M 223K -2.39M
Change in Working Capital
-36.67M 15.1M -125.88M -109.51M 51.65M -5.11M
Operating Cash Flow
209.86M 247.32M 250.86M 188.2M 362.66M 178.53M
Capital Expenditures
-39.39M -152.2M -113.86M -81.97M -66.1M -44.99M
Cash Acquisitions
-2.47M -1.01B -10.66M -61.29M -11.51M -27.25M
Purchase of Investments
-25.65M -3.9M -21.59M -5.85M -2.42M -25K
Sales Maturities Of Investments
n/a 750.02M 34.78M 56.01M -35.58M 163K
Other Investing Acitivies
-23.51M -65.32M -47.86M -55.79M 40.4M 153K
Investing Cash Flow
-91.03M -412.31M -110.98M -148.89M -75.2M -71.95M
Debt Repayment
68K 400.21M -8K -2.05M -17.31M -16.05M
Common Stock Repurchased
n/a -150.08M n/a n/a n/a n/a
Dividend Paid
-52.52M -98.2M -98.39M -80.5M -44.72M -58.14M
Other Financial Acitivies
-56.37M 24.32M -36.7M 44.31M -223.86M -48.78M
Financial Cash Flow
-108.83M 176.25M -135.09M -38.24M -285.89M -122.96M
Net Cash Flow
6.98M 9.68M 2.87M 290K 1.24M -17.44M
Free Cash Flow
170.46M 95.12M 137M 106.23M 296.56M 133.54M
Adj. Free Cash Flow
170.46M 95.12M 137M 106.23M 296.56M 133.54M
Maintenance CapEx
-17.82M -152.2M -94.63M -59.38M -41.83M -44.99M
Growth CapEx
-21.58M n/a -19.23M -22.59M -24.27M n/a
Owner Earnings
192.04M 95.12M 156.23M 128.81M 320.83M 133.54M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.